United States · FDA National Drug Code directory
Ipratropium Bromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76204-100_459b984d-b299-c7c0-e063-6294a90a3efd
- Product NDC
- 76204-100
- Form
- SOLUTION
- Composition / generic term
- Ipratropium Bromide
- Labeler
- Ritedose Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110201
- Source listing expiry
- 20261231
Source-listed ingredients
- IPRATROPIUM BROMIDE — .5 mg/2.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (76204-100-01) / 1 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE · 76204-100-01
- 1 POUCH in 1 CARTON (76204-100-25) / 25 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE · 76204-100-25
- 1 POUCH in 1 CARTON (76204-100-30) / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE · 76204-100-30
- 2 POUCH in 1 CARTON (76204-100-60) / 30 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE · 76204-100-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →